|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.14 USD | +0.39% |
|
-1.95% | +43.97% |
| Market Cap | 5.76B 4.99B 4.66B 4.27B 8.03B 549B 8.16B 54.63B 21.44B 275B 21.65B 21.17B 909B | P/E 2026 * |
40.2x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 8.04B 6.95B 6.49B 5.96B 11.2B 765B 11.38B 76.18B 29.9B 383B 30.18B 29.52B 1,268B | EV / Sales 2026 * |
2.56x | EV / Sales 2027 * | 2.25x |
| Free-Float |
47.1% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Amneal Pharmaceuticals, Inc.
| 1 day | +0.39% | ||
| 1 week | -1.95% | ||
| Current month | -0.98% | ||
| 1 month | +7.21% | ||
| 3 months | +33.19% | ||
| 6 months | +24.93% | ||
| Current year | +43.97% |
| 1 week | 17.93 |  | 19.15 |
| 1 month | 16.45 | | 19.26 |
| Current year | 11.71 | | 19.26 |
| 1 year | 8.21 | | 19.26 |
| 3 years | 3.36 | | 19.26 |
| 5 years | 1.24 | | 19.26 |
| 10 years | 1.24 | | 24.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chirag K. Patel
CEO | Chief Executive Officer | 59 | 2019-07-31 |
Chintu Patel
CEO | Chief Executive Officer | 54 | 2019-07-31 |
| Director of Finance/CFO | 58 | 2023-11-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Autor
BRD | Director/Board Member | 59 | 2023-11-06 |
J. Buchi
BRD | Director/Board Member | 70 | 2023-11-06 |
Jeffrey George
BRD | Director/Board Member | 52 | 2023-11-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/7/26 | Fiscal year | Director | 69,638 | 0.0218% | ||
| 11/17/25 | Sell | Director | 50,000 | 0.0159% | ||
| 11/12/25 | Fiscal year | Head of Human Resources | 395,568 | 0.1259% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.39% | -1.95% | +125.34% | +341.36% | 5.76B | |
| -0.52% | +2.66% | +58.86% | +163.79% | 1,062B | |
| +0.88% | +1.34% | +51.97% | +53.36% | 619B | |
| +0.89% | -4.42% | +25.34% | +66.55% | 431B | |
| +0.71% | +3.93% | +47.75% | +38.58% | 358B | |
| +0.64% | -0.63% | +36.39% | +41.44% | 293B | |
| +0.39% | -6.48% | +7.62% | +9.04% | 247B | |
| +1.51% | +6.01% | +44.36% | +68.92% | 219B | |
| +3.92% | -7.80% | +5.39% | -42.52% | 200B | |
| +1.80% | +1.47% | +20.79% | +69.31% | 162B | |
| Average | +1.13% | -1.94% | +42.38% | +80.98% | 359.8B | |
| Weighted average by Cap. | +0.63% | -0.83% | +41.73% | +78.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.14B 2.72B 2.54B 2.33B 4.38B 299B 4.45B 29.79B 11.69B 150B 11.8B 11.55B 496B | 3.39B 2.93B 2.74B 2.51B 4.72B 322B 4.8B 32.11B 12.6B 162B 12.72B 12.44B 534B |
| Net income | 149M 129M 120M 110M 207M 14.16B 211M 1.41B 554M 7.1B 559M 547M 23.47B | 295M 255M 238M 218M 411M 28.05B 417M 2.79B 1.1B 14.06B 1.11B 1.08B 46.48B |
| Net Debt | 2.27B 1.97B 1.84B 1.68B 3.17B 216B 3.22B 21.54B 8.46B 108B 8.54B 8.35B 358B | 1.85B 1.6B 1.49B 1.37B 2.58B 176B 2.62B 17.52B 6.88B 88.17B 6.94B 6.79B 291B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | US$18.14 | +0.39% | 1,089,573 |
| 26-08-06 | US$18.07 | -2.11% | 1,404,643 |
| 26-08-05 | US$18.46 | -0.11% | 1,865,070 |
| 26-08-04 | US$18.48 | -1.96% | 2,128,113 |
| 26-08-03 | US$18.85 | +2.89% | 2,487,790 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMRX Stock
Select your edition
All financial news and data tailored to specific country editions
